Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
about
Evaluating Healthcare Claims for Neurocysticercosis by Using All-Payer All-Claims Data, Oregon, 2010-2013.Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory featuresClinical Symptoms, Imaging Features and Cyst Distribution in the Cerebrospinal Fluid Compartments in Patients with Extraparenchymal Neurocysticercosis.Immunopathology in Taenia solium neurocysticercosis.Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis.Disease Centered Around Calcified Taenia solium Granuloma.Surgical treatment of neurocysticercosis. Retrospective cohort study and an illustrative case report.Recent advancements and new perspectives in animal models for Neurocysticercosis immunopathogenesis.Taenia crassiceps injection into the subarachnoid space of rats simulates radiological and morphological features of racemose neurocysticercosis.Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin.Comparison of T24H-his, GST-T24H and GST-Ts8B2 recombinant antigens in western blot, ELISA and multiplex bead-based assay for diagnosis of neurocysticercosis.The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis.Neurocysticercosis in Pregnancy.Pre-hospitalization, hospitalization, and post-hospitalization costs of patients with neurocysticercosis treated at the Instituto Nacional de Neurologia y Neurocirugia (INNN) in Mexico City, Mexico.Inflammation is a key risk factor for persistent seizures in neurocysticercosis.Laboratory Diagnosis of Neurocysticercosis (Taenia solium)Carotid Oncosphere Infection: A Novel Porcine Neurocysticercosis Model
P2860
Q31143611-1BE72F44-360F-476B-9810-F957847B594BQ33821964-98816445-1197-4F5E-BD17-D1E41D4BCC7DQ36187258-BFD33759-DD32-432D-A67F-E0D83989C8F3Q38669389-930C128F-913F-4FFE-92F9-1936987FABE2Q38844933-FC09EA68-698E-41F7-A800-9F1EDA118F55Q38976262-A1D19800-DA6B-4A4A-8BAF-179EA2CC5261Q39222278-15C78763-C09D-4440-BB1A-10094A5D362AQ39280564-243FD33C-AFBC-4611-9789-6D6ADDC04244Q40544919-0C5C46D9-9CC9-42DD-BDCA-1532D572404DQ41717026-1BBAD02C-30A9-495E-B41E-B768B2498AE1Q42091729-39A9704F-430B-4AD7-9A9B-9AD9DE54778DQ52630982-41BB8FCE-F1D6-475A-983E-5E9301D50A73Q54238191-4DA4EE57-64B0-4D15-91A9-F56629A4EAB5Q55027714-5DCDDA8B-5C13-4CCA-912D-2519FB02947FQ55216162-22C1DBCA-9968-4A52-A899-862D1C665149Q56340364-BC2784C9-8323-46EB-A9BA-DF2DC18DCA86Q57171412-047424CC-02CD-42A7-8493-E2663962B833
P2860
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@ast
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@en
type
label
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@ast
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@en
prefLabel
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@ast
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@en
P2860
P356
P1476
Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.
@en
P2093
Robert H Flecker
Seth E O'Neal
P2860
P304
P356
10.3201/EID2106.141324
P577
2015-06-01T00:00:00Z